🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGLP-1/GIP receptor co-agonism — anyone have experience? Page 4

GLP-1/GIP receptor co-agonism — anyone have experience?

Dr.NephBHM_UK Mon, Jan 5, 2026 at 2:36 AM 36 replies 1,378 viewsPage 4 of 8
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jan 5, 2026 at 8:16 AM#16

Just wanted to say — for anyone reading this GLP-1/GIP receptor thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

38 23VendorMark, COA_Karl, MikeFit_NJ and 35 others
Reply Quote Save Share Report
nick_newbie
New Member
18
56
Mar 2026
Virginia
Online
Jan 5, 2026 at 8:33 AM#17

Dr.NephBHM_UK's experience with GLP-1/GIP receptor resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 64 lbs in 9 months.

One thing I would add that Dr.NephBHM_UK did not mention: the relationship with food fundamentally changed.

34 0dan_philly, MeganSA_TX, LarryQC_SD and 31 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Jan 5, 2026 at 8:50 AM#18

Saving this for reference. Quality thread.

4 0Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 1 other
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jan 5, 2026 at 9:07 AM#19

As a healthcare provider, I want to add some clinical context to this discussion on GLP-1/GIP receptor co-agonism anyone.

Building on what Dr.NephBHM_UK said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Jan 5, 2026 at 2:07 PM
14 6Dr.RaviCardio, jennifer_SEA, tyler_CSCS and 11 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Jan 5, 2026 at 9:24 AM#20

Subscribing to this thread. GLP-1/GIP receptor is exactly what I've been researching. 🙏

Last edited: Jan 5, 2026 at 12:24 PM
29 16B12Beth, RickReta_CO, PharmHunterJen and 26 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register